Related Experiment Video
Updated: Mar 28, 2026

08:46
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
6.9K
Open versus closed oocyte vitrification in an oocyte donation programme: a prospective randomized sibling oocyte
N De Munck1, S Santos-Ribeiro2, D Stoop3
1Centre for Reproductive Medicine, UZ Brussel, Laarbeeklaan 101, Brussels, Belgium Reproduction and Genetics, Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, Brussels, Belgium neelke.demunck@uzbrussel.be.
Human Reproduction (Oxford, England)
|January 3, 2016
Summary
The CryotopSC and CBSvit devices demonstrated similar oocyte survival rates in vitrification. CryotopSC showed improved zygote development and embryo quality, addressing concerns about closed vitrification devices.
Area of Science:
- Reproductive medicine
- Embryology
- Cryobiology
Background:
- Health authorities express caution regarding potential cross-contamination with open vitrification devices.
- Limited data exists on the efficiency of closed vitrification devices, leading to their continued use.
Purpose of the Study:
- To compare the donor oocyte survival rates between the CryotopSC (open vitrification) and CBSvit (closed vitrification) devices.
- To evaluate embryological outcomes, including survival, fertilization, and embryo development, following vitrification with both devices.
Main Methods:
- A prospective randomized sibling oocyte study involving 48 donors and comparing 253 oocytes vitrified with CBSvit and 257 with CryotopSC.
- Oocytes were vitrified using either the CBSvit (closed) or CryotopSC (open) device and warmed for subsequent assessment of survival and embryological development.
- Statistical analysis was performed to compare outcomes between the two devices, with a 10% difference defined as proof of CryotopSC superiority.
Main Results:
- No significant difference in oocyte survival rates after warming (93.7% for CBSvit vs. 89.9% for CryotopSC).
- CryotopSC showed a significantly lower degeneration rate after ICSI (6.1% vs. 11.4%) and a higher rate of first mitosis completion (52.1% vs. 34.1%).
- Embryos in the CryotopSC group had a significantly higher cell number on Day 3 (7.6 ± 2.8 vs. 6.8 ± 2.8), with similar overall embryo quality distribution.
Conclusions:
- Both CryotopSC and CBSvit devices exhibit comparable oocyte survival rates.
- The CryotopSC device demonstrates superior performance in terms of reduced degeneration and enhanced embryo development.
- The study highlights the efficiency of a closed vitrification device (CBSvit), potentially alleviating concerns about cross-contamination during handling and storage.
Related Concept Videos
In Vitro Fertilization
1.3K
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
1.3K
Meiosis II
210.5K
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...
210.5K

